Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-29Clinical Trial Update: Study of Patients Receiving DUPIXENT® for Atopic Dermatitis (AD)
This update provides the current status of a Dupixent (dupilumab) trial for atopic dermatitis, noting that the study is active but not recru…
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: Efficacy and Safety of Revodiol Calming Cream® in Atopic Dermatitis. [NA]
This clinical trial update reports the efficacy and safety results of Revodiol Calming Cream for atopic dermatitis in a completed study.
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (Integument-PED) [Phase 3]
A Phase 3 trial evaluating roflumilast, a PDE4 inhibitor, for the management of atopic dermatitis (eczema) has completed and results have be…
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: A Study to Assess Bioavailability of Rocatinlimab (AMG 451) Vial and Prefilled Syringe in Healthy Participants [Phase 1]
Phase 1 study assessing the bioavailability of Rocatinlimab (AMG 451) when administered via vial versus prefilled syringe in healthy partici…
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Open Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis [Phase 3]
An open-label Phase 3 extension trial evaluating roflumilast, a PDE-4 inhibitor, for the management of atopic dermatitis; the trial has comp…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Study to Investigate the Effect of Rocatinlimab (AMG 451) on the Pharmacokinetics of Multiple Cytochrome P450 (CYP450) Substrates in Participants With Moderate to Severe Atopic Dermatitis [EARLY_Phase 1]
An early-phase study evaluating whether Rocatinlimab (AMG 451) alters the pharmacokinetics of multiple cytochrome P450 substrates in adults …
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: A Study of Orally Administered IPG7236 in Healthy Adult Participants [Phase 1]
Phase 1 study of oral IPG7236 in healthy adults for atopic dermatitis has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: The Purpose of This Study is to Evaluate the Effects of Ruxolitinib Cream on Adults With Atopic Dermatitis Experiencing Sleep Disturbance. [Phase 4]
Phase 4 trial evaluating the effects of ruxolitinib cream in adults with atopic dermatitis and sleep disturbance; the study was terminated w…
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Topical YR001 Ointment in Adult With Mild to Moderate Atopic Dermatitis [Phase 2]
A Phase 2 trial evaluating Topical YR001 Ointment in adults with mild to moderate atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: An Evaluation of 9MW1911 Injection in Healthy Subjects [Phase 1]
Phase 1 evaluation of 9MW1911 Injection in healthy subjects has been completed, assessing safety in potential indications including asthma, …
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: Baricitinib Versus Azathioprine in Patients With Moderate-to-Severe Atopic Dermatitis [NA]
A completed clinical trial compared baricitinib to azathioprine in patients with moderate-to-severe atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2025-12-12Clinical Trial Update: Comparative Analysis of Filmed Sequences for the Assessment of Discomfort in Atopic Dermatitis of Infants Under 6 Months of Age [NA]
This clinical trial update indicates that the study evaluating filmed sequences to assess discomfort in infants under 6 months with atopic d…
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Efficacy of Rocatinlimab in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) [Phase 3]
Phase 3 clinical trial assessing Rocatinlimab in adolescent participants with moderate-to-severe Atopic Dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: Tofacitinib for Immune Skin Conditions in Down Syndrome [Phase 2]
A Phase 2 trial evaluating tofacitinib for immune-mediated skin conditions in individuals with Down syndrome has completed, with results pos…
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: Phase 2 Study of SAR444656 in Adult Participants With Moderate to Severe Atopic Dermatitis [Phase 2]
Sanofi reports that the Phase 2 trial of SAR444656 in adults with moderate to severe atopic dermatitis has been terminated. The update notes…
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: Safety Study of Roflumilast Cream 0.05% in Infants Aged 3 Months to Less Than 2 Years With Atopic Dermatitis [Phase 2]
Arcutis Biotherapeutics completed a Phase 2 safety trial evaluating Roflumilast Cream 0.05% in infants aged 3 months to under 2 years with a…
-
CLINICAL_TRIALS trial_result · 2025-12-09Clinical Trial Update: A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Called Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female Participants [Phase 1]
Pfizer is studying PF-08049820 in a Phase 1 trial to see if it changes how the body processes oral contraceptives, midazolam, and dabigatran…
-
CLINICAL_TRIALS trial_result · 2025-12-09Clinical Trial Update: A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring
This clinical trial update indicates that a study of the safety of Abrocitinib (CIBINQO) in pregnant women and their offspring is currently …
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986326 in Participants With Atopic Dermatitis [Phase 1]
This clinical trial update reports the completion of a Phase 1 study evaluating safety, tolerability, drug levels (pharmacokinetics), and dr…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Efficacy Study of EVO301 in Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 efficacy trial of EVO301 in moderate-to-severe atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: A Study of LY3454738 in the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis [Phase 2]
A Phase 2 study of LY3454738 in adults with moderate-to-severe Atopic Dermatitis was terminated, and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroids [Phase 3]
Phase 3 trial evaluating subcutaneous amlitelimab for moderate-to-severe atopic dermatitis in participants aged 12 and older on topical cort…
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: Multiple Ascending-Dose Study of XmAb®27564 in Patients With Psoriasis or Atopic Dermatitis [Phase 1]
A Phase 1 multiple ascending-dose study of XmAb®27564 in psoriasis and atopic dermatitis has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: The Efficacy of Patients With Moderate to Severe Atopic Dermatitis Treated With Chinese Herbal Medicine [Phase 3]
A Phase 3 trial assessing the efficacy of a Chinese Herbal Medicine formulation for moderate to severe atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE) [Phase 3]
Phase 3 ROCKET-IGNITE trial evaluating Rocatinlimab for moderate-to-severe atopic dermatitis has completed.